サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439276

神経診断・モニタリング機器 - 世界市場の考察、競合情勢、市場予測（2030年）

Neurological Diagnostic and Monitoring Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
神経診断・モニタリング機器 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経診断・モニタリング機器の市場規模は、2023年に118億1,000万米ドル、2030年までに173億3,000万米ドルに達し、2024年～2030年の予測期間にCAGRで6.66％の成長が見込まれます。神経診断・モニタリング機器に対する需要の増加は主に、神経障害の有病率の増加に加え、老年人口の増加、外傷性脳損傷の罹患率の増加、製品ポートフォリオにおける技術の進歩、神経障害と適切な管理に向けた早期診断に関する患者の意識を高める政府の取り組みの高まりによって促進されています。

神経診断・モニタリング機器の市場力学

世界の神経診断・モニタリング機器市場の成長は、てんかん、脳卒中、パーキンソン病などの神経疾患の有病率が世界中で上昇しているため急加速しています。WHO（2022）によると、てんかんは慢性的な脳疾患であり、全世界で約5,000万人が罹患し、その80%が低中所得国であることから、世界の疾病負担の大きな割合を占めています。また、適切な診断と治療を受ければ、てんかん患者の70％が発作を起こさずにすむと推定されています。

さらに、世界の人々の脳腫瘍やがんの罹患率も増加傾向にあります。例えば、Global Cancer Observatory（2020）の統計によると、2020年に世界全体で30万8,102件の脳腫瘍と中枢神経系がんの新たな症例が発生しています。したがって、患者数の増加とこれらの疾患の早期診断の必要性により、神経診断・モニタリング機器の需要が増加する可能性があり、これがさらに世界の神経診断・モニタリング機器市場を押し上げると予測されます。

さらに、先進技術を利用した神経診断機器の製品承認は、世界の神経診断・モニタリング機器市場を急成長させる可能性が高いです。例えば近年、2020年1月にCompumedics Limitedは、特許取得済みのDROS; SQUIDセンサーシステムを搭載したOrion LifeSpanTM MEGの米国FDA承認を取得しました。

しかし、熟練した専門家の不足や、手術や脳モニタリング用機器の高いコストなどの特定の要因が、特に償還政策が低い先進国において、神経診断・モニタリング機器の世界の需要を制限する主な要因となっています。

神経診断・モニタリング機器市場のセグメント分析

神経診断・モニタリング機器製品セグメントでは、予測期間に脳波計（EEG）が大きな市場を占めます。これは、8、21、25、32などのさまざまなチャネルを持つスタンドアロン型と携帯型のEEGモデルが利用可能なためです。さらに、EEGセグメントの成長に寄与するその他の要因として、軽量化、携帯性、生データの同時取得などの技術の進歩に対するメーカーの注目の高まりがあります。また、臨床診療や屋外調査向けの携帯型機器に対する需要の増加が、セグメントの成長を増強すると予測されています。

さらに近年、2019年にNihon Kohdenは、意識のない患者の脳の健康状態を迅速に評価するVitalEEG（TM）を発売しました。このシステムは、臨床医が病院内のどこからでも重要な情報を評価できるリモートアクセス機能と、追加のケーブルが不要なBluetooth通信の両方を提供します。

このような製品の発売も、予測期間の神経診断・モニタリング機器市場のセグメント成長を促進すると予測されます。

北米が神経診断・モニタリング機器市場全体を独占すると予測される

予測期間に北米が神経診断・モニタリング機器市場全体を独占する見込みです。この優位性は、外傷性脳損傷（TBI）の罹患率の増加、医療費の増加、同地域の整備された先進医療システムのプレゼンスによるものです。さらに、適切な償還政策が促進要因となっています。

例えば、CDCの2022年のレポートによると、2019年、米国では約6万1,000人のTBI関連の死亡がありました。また、調査研究によると、米国では約170万人が外傷性脳損傷を負っており、中でも15歳～19歳の青少年と65歳以上の成人が外傷性脳損傷を負う可能性が高いと推定されています。

当レポートでは、世界の神経診断・モニタリング機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 神経診断・モニタリング機器レポートのイントロダクション

第2章 神経診断・モニタリング機器のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 神経診断・モニタリング機器市場の主な要因の分析

  • 神経診断・モニタリング機器市場の促進要因
    • 老年人口の増加に伴う神経疾患の有病率の増加
    • 外傷性脳損傷の罹患率の増加
    • 製品ポートフォリオにおける技術の進歩
    • 神経障害と適切な管理に向けた早期診断に関する患者の意識を高める政府の取り組みの高まり
  • 神経診断・モニタリング機器市場の抑制要因と課題
    • 機器と処置の高いコスト
    • 熟練労働者の不足
  • 神経診断・モニタリング機器市場の機会
    • 非侵襲性の機器に対する需要の高まり
    • 発展途上国における市場成長機会

第5章 神経診断・モニタリング機器のポーターのファイブフォース分析

第6章 神経診断・モニタリング機器の市場レイアウト

  • タイプ別
    • 侵襲性
    • 非侵襲性
  • 製品タイプ別
    • 脳磁図機器（MEG）
    • 脳波検査機器（EEG）
    • 経頭蓋ドップラー超音波検査機器
    • 脳酸素濃度計
    • 頭蓋内圧モニター
    • その他
  • 適応症別
    • てんかん
    • 外傷性脳損傷
    • 脳卒中
  • エンドユーザー別
    • 病院
    • 診断センター・イメージングセンター
  • 地域別
    • 北米の神経診断・モニタリング機器の市場規模
    • 欧州の神経診断・モニタリング機器の市場規模（2021年～2030年）
    • アジア太平洋の神経診断・モニタリング機器の市場規模（2021年～2030年）
    • その他の地域の神経診断・モニタリング機器の市場規模（2021年～2030年）

第7章 神経診断・モニタリング機器の企業と製品のプロファイル

  • Natus Medical, Inc
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V.
  • Compumedics Limited
  • Croton Healthcare
  • Ricoh
  • Elekta AB
  • Integra LifeSciences
  • RAUMEDIC AG
  • Masimo
  • Cadwell® Industries Inc.
  • Nonin
  • Neurosoft
  • Brain Scientific, Inc.
  • Recorders & Medicare Systems Pvt Ltd (RMS)
  • Rimed
  • Allengers
  • Medtronic
  • Edwards Lifesciences Corporation.
  • Ybrain, INC

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neurological Diagnostic and Monitoring Equipment Market in Global (2021-2030)
  • Table 3: Neurological Diagnostic and Monitoring Equipment Market in Global by Type (2021-2030)
  • Table 4: Neurological Diagnostic and Monitoring Equipment Market in Global by Product Type (2021-2030)
  • Table 5: Neurological Diagnostic and Monitoring Equipment Market in Global by Indication (2021-2030)
  • Table 6: Neurological Diagnostic and Monitoring Equipment Market in Global by End-User (2021-2030)
  • Table 7: Neurological Diagnostic and Monitoring Equipment Market in Global by Geography (2021-2030)
  • Table 8: Neurological Diagnostic and Monitoring Equipment Market in North America (2021-2030)
  • Table 9: Neurological Diagnostic and Monitoring Equipment Market in the US (2021-2030)
  • Table 10: Neurological Diagnostic and Monitoring Equipment Market in Canada (2021-2030)
  • Table 11: Neurological Diagnostic and Monitoring Equipment Market in Mexico (2021-2030)
  • Table 12: Neurological Diagnostic and Monitoring Equipment Market in Europe (2021-2030)
  • Table 13: Neurological Diagnostic and Monitoring Equipment Market in France (2021-2030)
  • Table 14: Neurological Diagnostic and Monitoring Equipment Market in Germany (2021-2030)
  • Table 15: Neurological Diagnostic and Monitoring Equipment Market in the United Kingdom (2021-2030)
  • Table 16: Neurological Diagnostic and Monitoring Equipment Market in Italy (2021-2030)
  • Table 17: Neurological Diagnostic and Monitoring Equipment Market in Spain (2021-2030)
  • Table 18: Neurological Diagnostic and Monitoring Equipment Market in Rest of Europe (2021-2030)
  • Table 19: Neurological Diagnostic and Monitoring Equipment Market in Asia-Pacific (2021-2030)
  • Table 20: Neurological Diagnostic and Monitoring Equipment Market in China (2021-2030)
  • Table 21: Neurological Diagnostic and Monitoring Equipment Market in Japan (2021-2030)
  • Table 22: Neurological Diagnostic and Monitoring Equipment Market in India (2021-2030)
  • Table 23: Neurological Diagnostic and Monitoring Equipment Market in Australia (2021-2030)
  • Table 24: Neurological Diagnostic and Monitoring Equipment Market in South Korea (2021-2030)
  • Table 25: Neurological Diagnostic and Monitoring Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Neurological Diagnostic and Monitoring Equipment Market in the Rest of the World (2021-2030)
  • Table 27: Neurological Diagnostic and Monitoring Equipment Market in the Middle East (2021-2030)
  • Table 28: Neurological Diagnostic and Monitoring Equipment Market in Africa (2021-2030)
  • Table 29: Neurological Diagnostic and Monitoring Equipment Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neurological Diagnostic and Monitoring Equipment Market in Global (2021-2030)
  • Figure 3: Neurological Diagnostic and Monitoring Equipment Market in Global by Type (2021-2030)
  • Figure 4: Neurological Diagnostic and Monitoring Equipment Market in Global by Product Type (2021-2030)
  • Figure 5: Neurological Diagnostic and Monitoring Equipment Market in Global by Indication (2021-2030)
  • Figure 6: Neurological Diagnostic and Monitoring Equipment Market in Global by End-User (2021-2030)
  • Figure 7: Neurological Diagnostic and Monitoring Equipment Market in Global by Geography (2021-2030)
  • Figure 8: Neurological Diagnostic and Monitoring Equipment Market in North America (2021-2030)
  • Figure 9: Neurological Diagnostic and Monitoring Equipment Market in the US (2021-2030)
  • Figure 10: Neurological Diagnostic and Monitoring Equipment Market in Canada (2021-2030)
  • Figure 11: Neurological Diagnostic and Monitoring Equipment Market in Mexico (2021-2030)
  • Figure 12: Neurological Diagnostic and Monitoring Equipment Market in Europe (2021-2030)
  • Figure 13: Neurological Diagnostic and Monitoring Equipment Market in France (2021-2030)
  • Figure 14: Neurological Diagnostic and Monitoring Equipment Market in Germany (2021-2030)
  • Figure 15: Neurological Diagnostic and Monitoring Equipment Market in the United Kingdom (2021-2030)
  • Figure 16: Neurological Diagnostic and Monitoring Equipment Market in Italy (2021-2030)
  • Figure 17: Neurological Diagnostic and Monitoring Equipment Market in Spain (2021-2030)
  • Figure 18: Neurological Diagnostic and Monitoring Equipment Market in Rest of Europe (2021-2030)
  • Figure 19: Neurological Diagnostic and Monitoring Equipment Market in Asia-Pacific (2021-2030)
  • Figure 20: Neurological Diagnostic and Monitoring Equipment Market in China (2021-2030)
  • Figure 21: Neurological Diagnostic and Monitoring Equipment Market in Japan (2021-2030)
  • Figure 22: Neurological Diagnostic and Monitoring Equipment Market in India (2021-2030)
  • Figure 23: Neurological Diagnostic and Monitoring Equipment Market in Australia (2021-2030)
  • Figure 24: Neurological Diagnostic and Monitoring Equipment Market in South Korea (2021-2030)
  • Figure 25: Neurological Diagnostic and Monitoring Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Neurological Diagnostic and Monitoring Equipment Market in the Rest of the World (2021-2030)
  • Figure 27: Neurological Diagnostic and Monitoring Equipment Market in the Middle East (2021-2030)
  • Figure 28: Neurological Diagnostic and Monitoring Equipment Market in Africa (2021-2030)
  • Figure 29: Neurological Diagnostic and Monitoring Equipment Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0066

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (Meg), Electroencephalography Devices (Eeg), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography is expected to grow at a static CAGR forecast till 2030 due to advances in product portfolio and burgeoning neurological disorder prevalence among the aging population.

The global neurological diagnostic and monitoring equipment market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030. The rise in demand for neurological diagnostic and monitoring equipment is primarily motivated by the increasing prevalence of neurological disorders along with the rising aging population, growing incidence of traumatic brain injuries, technological advancement in the product portfolio, the rising government initiatives to raise awareness among patient regarding neurological disorders and their early diagnosis for proper management, among others.

Neurological Diagnostic and Monitoring Equipment Market Dynamics:

The global neurological diagnostic and monitoring equipment market growth is burgeoning due to the rising prevalence of neurological disorders such as epilepsy, stroke, and Parkinson's among others across the globe. According to WHO 2022, epilepsy is a chronic brain disorder that accounts for a significant proportion of the world's disease burden by affecting around 50 million people across the globe with 80% of the cases in low and middle-income nations. Also, the report mentions that an estimated 70% of people with epilepsy could be seizure-free if properly diagnosed and treated.

Moreover, the incidence of brain tumors and cancer among the world population is also on the rise. For instance, as per the Global Cancer Observatory 2020 statistics, globally there were 308,102 new cases of brain and central nervous system cancer new cases in 2020. Therefore, the rising patient population and the need for early diagnosis of these disorders could increase the demand for neurodiagnostic and monitoring devices which further is expected to boost the global neurological diagnostic and monitoring equipment market.

Further, product approval of technologically advanced neurodiagnostic devices is likely to upsurge the global neurological diagnostic and monitoring equipment market. For example, recently in January 2020, Compumedics Limited received US FDA approval for Orion LifeSpanTM MEG with a patented double relaxation oscillator superconducting quantum interference device (DROS; SQUID) sensor system.

However, certain factors such as the dearth of skilled professionals and the high cost of surgery and devices for brain monitoring are major factors limiting the global demand for neurological diagnostic and monitoring equipment, especially in developed countries with low reimbursement policies.

Neurological Diagnostic and Monitoring Equipment Market Segment Analysis:

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (MEG), Electroencephalography Devices (EEG), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the neurological diagnostic and monitoring equipment product segment, electroencephalography devices (EEG) hold a significant market during the forecasted period. This is owing to the availability of standalone as well as portable EEG models with different channels such as 8, 21, 25, and 32, among others. Moreover, other factors that contribute to the growth of the EEG segment are the growing focus of manufacturers towards technological advancements, such as lightweight, portability, and the acquisition of raw data simultaneously. Also, the increasing demand for portable devices for clinical practice and outdoor investigation is projected to augment the segment growth.

Furthermore, recently in 2019, Nihon Kohden launched VitalEEG(TM) to rapidly assess brain health in unconscious patients. The system provides both remote access functionality, so clinicians can assess critical information from anywhere in the hospital, and Bluetooth communication, eliminating the need for additional cables.

Thus such product launches are also expected to fuel the segmental growth of the neurological diagnostic and monitoring equipment market during the forecasted period.

North America is expected to dominate the overall Neurological Diagnostic and Monitoring Equipment Market:

North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period. This domination is due growing incidence of traumatic brain injuries (TBI), the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

For instance, as per the CDC 2022 report, in 2019, there were nearly 61,000 TBI-related deaths in the US. Also, research studies have estimated that in the US, approximately 1.7 million people suffer a traumatic brain injury, with adolescents between ages 15 and 19 and adults aged 65 and older among the most likely to sustain a traumatic brain injury.

The presence of key market players such as Masimo Corporation, Compumedics Limited, and Natus Medical Incorporated, among others in the region is likely to boost the neurological diagnostic and monitoring equipment market.

Moreover, an increase in product approval in the region is also a driving factor for the Neurological Diagnostic and Monitoring Equipment in the region. For instance, in August 2020, Masimo announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains.

Thus, the aforementioned factors are likely to upsurge the market for neurological diagnostic and monitoring equipment in the region.

Neurological Diagnostic and Monitoring Equipment Market Key Players:

Some of the key market players operating in the neurological diagnostic and monitoring equipment market include Natus Medical, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

Recent Developmental Activities in the Neurological Diagnostic and Monitoring Equipment Market:

In March 2022, Brain Scientific received FDA Clearance for Next-Gen NeuroCap(TM) EEG Headset, an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where the recording of STAT EEGs is desired.

In October 2020, MEGIN announced Japan Expansion by launching MEGIN KK in Tokyo.

In December 2019, Raumedic, a medical technology manufacturer, launched a new home-use device, named Raumed Home ICP, for intracranial pressure (ICP) monitoring. The product was developed for patients suffering from hydrocephalus.

Key Takeaways from the Neurological Diagnostic and Monitoring Equipment Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global neurological diagnostic and monitoring equipment market.

Various opportunities available for the other competitor in the neurological diagnostic and monitoring equipment market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for neurological diagnostic and monitoring equipment market growth in the coming future?

Target Audience who can be benefited from Neurological Diagnostic and Monitoring Equipment Market Report Study

Neurological Diagnostic and Monitoring Equipment providers

Research organizations and consulting companies

Neurological Diagnostic and Monitoring Equipment-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in neurological diagnostic and monitoring equipment

Various End-Users who want to know more about the neurological diagnostic and monitoring equipment market and the latest technological developments in the neurological diagnostic and monitoring equipment market.

Frequently Asked Questions for Neurological Diagnostic and Monitoring Equipment Market:

1. What is Neurological Diagnostic and Monitoring Equipment?

Neurological Diagnostic and Monitoring Equipment are the devices used for the diagnosis of neurological disorders such as stroke, migraine, epilepsy, Parkinson's disease, and ischemic stroke, among others. There are various equipment available in the market such as EEG, MEG, Cerebral Oximeters, among others.

2. What is the market for global neurological diagnostic and monitoring equipment?

The global Neurological Diagnostic and Monitoring Equipment Market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030.

3. What are the drivers for global neurological diagnostic and monitoring equipment?

The major factors driving the demand for Neurological Diagnostic and Monitoring Equipment are the growing prevalence of neurological disorders coupled with the rising geriatric population, the increasing incidence of traumatic brain injuries, and the launch of technically advanced products in the market.

4. Who are the key players operating in global neurological diagnostic and monitoring equipment?

Some of the key market players operating in the neurological diagnostic and monitoring equipment market include natus medical, inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

5. Which region has the highest share in the neurological diagnostic and monitoring equipment market?

North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period, 2024-2030. this domination is because of the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

Table of Contents

1. Neurological Diagnostic and Monitoring Equipment Report Introduction

2. Neurological Diagnostic and Monitoring Equipment Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Neurological Diagnostic and Monitoring Equipment Market Key Factors Analysis

  • 4.1. Neurological Diagnostic and Monitoring Equipment Market Drivers
    • 4.1.1. Increasing prevalence of neurological disorders coupled with the rising aging population
    • 4.1.2. Growing Incidence of Traumatic Brain Injuries
    • 4.1.3. Technological advancement in the product portfolio
    • 4.1.4. Rising government initiative to raise awareness among patients regarding neurological disorders and their early diagnosis for proper management
  • 4.2. Neurological Diagnostic and Monitoring Equipment Market Restraints and Challenges
    • 4.2.1. High cost of the devices and procedure
    • 4.2.2. The dearth of skilled labors
  • 4.3. Neurological Diagnostic and Monitoring Equipment Market Opportunities
    • 4.3.1. Growing demand for non-invasive devices
    • 4.3.2. Market growth opportunities in developing nations

5. Neurological Diagnostic and Monitoring Equipment Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Neurological Diagnostic and Monitoring Equipment Market Layout

  • 6.1. By Type
    • 6.1.1. Invasive
    • 6.1.2. Non-invasive
  • 6.2. By Product Type
    • 6.2.1. Magnetoencephalography Devices (MEG)
    • 6.2.2. Electroencephalography Devices (EEG)
    • 6.2.3. Transcranial Doppler Sonography Devices
    • 6.2.4. Cerebral Oximeters
    • 6.2.5. Intracranial Pressure Monitors
    • 6.2.6. Others
  • 6.3. By Indication
    • 6.3.1. Epilepsy
    • 6.3.2. Traumatic Brain Injuries
    • 6.3.3. Stroke
    • 6.3.4. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic & Imaging Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Neurological Diagnostic and Monitoring Equipment Market Size in USD million 2021-2030)
      • 6.5.1.1. United States Neurological Diagnostic and Monitoring Equipment Market Size in USD million 2021-2030)
      • 6.5.1.2. Canada Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.2. Europe Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.1. France Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.1. China Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.3. India Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia Pacific Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.1. Middle East Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)

7. Neurological Diagnostic and Monitoring Equipment Company and Product Profiles

  • 7.1. Natus Medical, Inc
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nihon Kohden Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Koninklijke Philips N.V.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Compumedics Limited
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Croton Healthcare
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Ricoh
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Elekta AB
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Integra LifeSciences
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. RAUMEDIC AG
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Masimo
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Cadwell® Industries Inc.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Nonin
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Neurosoft
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Brain Scientific, Inc.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Recorders & Medicare Systems Pvt Ltd (RMS)
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Rimed
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Allengers
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Medtronic
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Edwards Lifesciences Corporation.
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Ybrain, INC
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us